BH10 Unequal National Health Service wig provision: toupée or no toupée, that is the question?
Marianne de Brito,Amy Johnson,Sue Schilling,Leila Asfour,Nick J Levell
DOI: https://doi.org/10.1093/bjd/ljae090.157
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract The psychological impact of alopecia on patients’ quality of life can be significant. Patients may experience loss of confidence, discrimination, social anxiety and other mental health disorders as a result. In the absence of effective and well-tolerated treatments available in the National Health Service (NHS) to treat the underlying cause of the alopecia, wigs can provide an opportunity for patients to live confidently, free of stigma and visible differences. The Alopecia UK Charter for Best Practice for Wigs Provision aimed to support fair and equitable wig provision across the UK, work that was supported by NHS England and NHS Improvement. We investigated wig provision across nonprivate patients in the UK via an online survey. We circulated a three-question, 1-minute survey to dermatology doctors and healthcare professionals seeing nonprivate patients within NHS trusts (England), health boards (Wales and Scotland) or health and social care trusts (Northern Ireland). This was via the Alopecia UK stand at the British Association of Dermatologists (BAD) Annual Meeting 2023, to the circulation of the British Hair and Nail Society membership and events, and via the BAD newsletter. We received 73 responses. Overall, for nonprivate patients with severe alopecia, most reported that wig provision would be straightforward (52%), but a large minority reported variable difficulty, due to patient or other factors (33%), and 5% reported it would be impossible. The remaining 10% did not know. There were respondents from all regions of the UK, with most from England: 59 (Northern Ireland: 2, Scotland: 3, Wales: 7, not stated: 2). The best-represented regions in England were the Midlands (14), the North West (14), North East and Yorkshire (10) and London (9), but there were responses from all regions. There was widespread variation in access to wig provision by different regions. All respondents from Scotland (3 of 3) and the South West (2 of 2) reported wig provision was straightforward, while all respondents from Northern Ireland (2 of 2) reported variable difficulty. At least 50% of the respondents from the East of England, London, Midlands, South East and North West reported wig provision was not straightforward. The findings of this survey reveal widespread variation in ease of access to wig provision throughout different regions of the UK. This demonstrates a lack of equality between patients with alopecia in different regions of the UK and impacts on patient choice. This goes against the Alopecia UK Charter for Best Practice for Wigs Provision. We hope that these findings will have implications at health policy level to improve and standardize access for all patients with alopecia who want and need a wig.
dermatology